Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA

Chiho Komoto1, Tsutomu Nakamura, Motohiro Yamamori

  • 1Department of Hospital Pharmacy, School of Medicine, Kobe University, Kobe 650-0017, Japan.

Insights

Calcium channel blockers can reverse multidrug resistance by down-regulating P-glycoprotein/MDR1. This study confirms their efficacy and suggests a novel mechanism involving MDR1 mRNA down-regulation for overcoming cancer drug resistance.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
  • P-glycoprotein (P-gp/MDR1) is a key transporter protein responsible for MDR.
  • Calcium (Ca2+) antagonists have shown potential in modulating P-gp activity.

Purpose of the Study:

  • To confirm the effects of 12 Ca2+ antagonists on MDR1-mediated drug transport and cellular sensitivity.
  • To investigate the underlying molecular mechanisms of Ca2+ antagonist-induced reversal of MDR.
  • To explore novel strategies for overcoming MDR in cancer treatment.

Main Methods:

  • Evaluation of Ca2+ antagonists' effects on [3H]digoxin transport mediated by P-gp.
  • Assessment of cellular sensitivity to vinblastine sulfate, paclitaxel, doxorubicin hydrochloride, and daunorubicin hydrochloride.
  • Measurement of [3H]vinblastine sulfate accumulation.
  • Analysis of MDR1 mRNA expression levels.

Main Results:

  • Ca2+ antagonists were classified into four subgroups based on their effects on P-gp transport and drug sensitivity.
  • Previous findings were confirmed using doxorubicin and daunorubicin resistance models.
  • Ca2+ antagonists effectively recovered [3H]vinblastine sulfate accumulation in resistant cells.
  • Sensitivity recovery was correlated with the down-regulation of MDR1 mRNA expression.

Conclusions:

  • Ca2+ antagonists can effectively reverse MDR mediated by P-gp.
  • Down-regulation of MDR1 mRNA represents a novel mechanism by which Ca2+ antagonists overcome MDR.
  • These findings suggest a potential therapeutic strategy for enhancing chemotherapy efficacy in resistant cancers.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...